Evaluation of Surgical-Site Infections Following Cardiovascular Surgery

Coşkun, Diler; Aytaç, Jale; Deveci, Seda; Sönmez, Emine

doi:10.1086/503501

Cited by 2 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The decreases in glycopeptide use were 31% for period 2 and 59% for period 3, relative to period 1. In our study, the expenditure for glycopeptides included the total amount of glycopeptides used for the following reasons: (1) treatment of MRSA infection, (2) treatment of methicillin-resistant coagulase-negative staphylococcus infection, (3) prophylaxis for patients admitted from other settings and undergoing revision surgery, (4) de-escalation therapy for patients with high fever, and (5) inappropriate use of glycopeptides by some consulting doctors from other settings.…”

Section: Discussionmentioning

confidence: 99%

The Decrease in Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Infections and Savings From Glycopeptide Use

Coşkun

Aytaç

2006

Infect. Control Hosp. Epidemiol.

View full text Add to dashboard Cite

We evaluated changes in the rate of healthcare-associated methicillin-resistant Staphylococcus aureus (MRSA) infections and healthcare-associated S. aureus infections after implementation of infection control precautions and the effect of this on glycopeptide use and expenditures for glycopeptides in a private medical center in Turkey in the years 2000-2005. A striking decrease was obtained in the number of MRSA infections, and the expenditure for glycopeptide use also decreased

show abstract

Section: Discussionmentioning

confidence: 99%

The Decrease in Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Infections and Savings From Glycopeptide Use

Coşkun

Aytaç

2006

Infect. Control Hosp. Epidemiol.

View full text Add to dashboard Cite

show abstract

Considerations in Prevention of Surgical Site Infections Following Cardiac Surgery

Streeter

2006

The Journal of Cardiovascular Nursing

View full text Add to dashboard Cite

The incidence of surgical site infections among patients with diabetes continues to occur at a greater rate when compared with their nondiabetic counterparts. Preexisting vascular changes, delayed wound healing, and impaired immune factors contribute. Adult patients with diabetes likely possess comorbid coronary artery disease, thus increasing the need for cardiac surgery. The resultant potential for infection can be combated with supplementary interventions above those universally taken. Modifiable risk factors of hyperglycemia and obesity are targeted preoperatively. Glycemic control, adequate tissue perfusion, and adjunct use of nasal mupirocin are addressed intraoperatively. Lastly, focus is placed on nutrition, exercise, and continued glucose control postoperatively and beyond discharge.

show abstract

Evaluation of Surgical-Site Infections Following Cardiovascular Surgery

Cited by 2 publications

References 8 publications

The Decrease in Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Infections and Savings From Glycopeptide Use

The Decrease in Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Infections and Savings From Glycopeptide Use

Considerations in Prevention of Surgical Site Infections Following Cardiac Surgery

Contact Info

Product

Resources

About